NCT02004652View on ClinicalTrials.gov

Prucalopride for Postoperative Ileus in Patients Undergoing Gastrointestinal Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Postoperative Ileus
Interventions
DRUG

Prucalopride

Prucalopride, 2mg, tablet. First given 24 hours after surgery beginning on POD 1,until bowel movements or for a maximum of 7 days of postoperative treatment

DRUG

Placebo

Vitamin, 50mg, tablet.

Trial Locations (1)

210002

Department of Generay Surgery, Jinling hosptal, Medical School of Nanjing University, Nanjing

All Listed Sponsors
lead

Jinling Hospital, China

OTHER

NCT02004652 - Prucalopride for Postoperative Ileus in Patients Undergoing Gastrointestinal Surgery | Biotech Hunter | Biotech Hunter